Form D Explorer

Form C — Eleison Pharmaceuticals Inc

0001665160-25-000014 · filed Jan 8, 2025 · via StartEngine Primary, LLC

Offering

Target
$124,000
Maximum
$1,235,000
Security type
Other
Price per security
—
Deadline
—
Oversubscription
Accepted

Issuer

CIK
1880047
Entity
Corporation
Jurisdiction
DE
Address
100 OVERLOOK CENTER, 2ND FLOOR
PRINCETON, NJ 08540
Phone
—

Most recent fiscal year financials

Total assets
$729,464
Cash
—
Short-term debt
$3,326,969
Long-term debt
$2,470,118
Revenues
—
COGS
—
Taxes paid
—
Net income
$-2,551,149

View the original filing on SEC EDGAR ↗